reference/13927733

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13927733

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	640
issn	0269-9370
issueIdentifier	4
pageRange	631-640
publicationName	AIDS (London, England)
startingPage	631
bibliographicCitation	Blanckenberg DH, Wood R, Horban A, Beniowski M, Boron-Kaczmarska A, Trocha H, Halota W, Schmidt RE, Fatkenheuer G, Jessen H, Lange JM; CHARM Study Group. Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects. AIDS. 2004 Mar 05;18(4):631–40. doi: 10.1097/00002030-200403050-00007. PMID: 15090768.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52067c6256d2aa710b541aa94d34e704 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5233c54feed29ed86bd1fa33530e9347 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56cc431329dd7b7f2aae8b84990d8511 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bee94fb5375e538b4dfa89403c1e6954 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34b8bbf0506e7ebc630294b2faa4d1e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_992d5d6b347c5dd716a3ab8bed056ae1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25c5bc6994de988d547a5b7c7568b0bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b46871784dcbbbc9295053715b02f09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39a1624162dde804f9c94d253d971543 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5855c119e1a88d547022e02445630b9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bb0745ffde6daa7cd6c044170ec457d
date	2004-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15090768 https://doi.org/10.1097/00002030-200403050-00007
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1493 https://portal.issn.org/resource/ISSN/0269-9370
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects
discusses	http://id.nlm.nih.gov/mesh/M0019224 http://id.nlm.nih.gov/mesh/M0029429 http://id.nlm.nih.gov/mesh/M0010790 http://id.nlm.nih.gov/mesh/M0028255
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018894Q000627 http://id.nlm.nih.gov/mesh/D019829Q000627 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D006918Q000627 http://id.nlm.nih.gov/mesh/D015497
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019829Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D018894Q000009 http://id.nlm.nih.gov/mesh/D006918Q000009 http://id.nlm.nih.gov/mesh/D019562 http://id.nlm.nih.gov/mesh/D018791 http://id.nlm.nih.gov/mesh/D015658Q000821 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012367Q000097 http://id.nlm.nih.gov/mesh/D023241Q000379 http://id.nlm.nih.gov/mesh/D015658Q000276 http://id.nlm.nih.gov/mesh/D023241Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4463 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3657 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.49

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128575040 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520807 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128738613

Total number of triples: 67.